Improving healthcare access for women who inject drugs in Seattle
Combination primary care and prevention services for women who inject drugs and exchange sex in Seattle, Washington
This study is working to make it easier for women who inject drugs in Seattle to get important HIV prevention and addiction treatment services by setting up a friendly clinic where they can walk in for help, especially in places they already visit.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Washington NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project ID | NIH-10886723 on NIH RePORTER |
What this research studies
This research focuses on enhancing access to HIV prevention and addiction treatment services for women who inject drugs (WWID) in Seattle. It aims to establish a co-located clinic that provides walk-in appointments at venues where these women may exchange sex, addressing significant barriers they face in accessing healthcare. The approach includes offering proven interventions like HIV pre-exposure prophylaxis (PrEP) and medications for opioid use disorder (MOUD) in a supportive environment. By integrating these services, the research seeks to improve both the uptake and sustained use of essential health interventions among this vulnerable population.
Who could benefit from this research
Good fit: Ideal candidates for this research are women who inject drugs and may also engage in transactional sex, particularly those facing barriers to accessing traditional healthcare services.
Not a fit: Patients who do not inject drugs or are not involved in transactional sex may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly reduce HIV transmission and improve overall health outcomes for women who inject drugs.
How similar studies have performed: Similar approaches have shown success in other countries, but this specific model has not yet been tested in the U.S.
Where this research is happening
Seattle, United States
- University of Washington — Seattle, United States (Active)
Researchers
- Principal investigator: Corcorran, Maria Ann — University of Washington
- Study coordinator: Corcorran, Maria Ann
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.